Approved Study Database

Ref. No. Scientific Title Principal investigator
2011.461 Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after docetaxel-based regimen Dr. HO Wing Ming
2011.177 A Phase II, single-arm study of orally administered BEZ235 as second-line therapy in patients with advanced or metastatic endometrial carcinoma Dr HO Wing Ming
2011.049 A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Dr. HO Wing Ming
2011.523 A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers Dr. Ho Wing Ming
2008.264 An International Multi-Centre Open Label 2-Arm Phase III Trial of Adjuvant Bevacizumab in Triple Negative Breast Cancer Dr. HO Wing Ming
2009.412 An open-label, multicenter phase II study to compare the efficacy and safety of RAD001 as first-line followed by second-line sunitinib versus sunitinib as first-line followed by second-line RAD001 in the treatment of patients with metastatic renal cell carcinoma Dr. Ho Wing Ming
2011.048 An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy Dr Ho Wing Ming
2007.471 A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open-Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with HER2 Negative Locally Recurrent or Metastatic Breast Cancer Dr. HO Wing Ming
2008.092 A Phase II Safety and Efficacy Study with the VEGF Receptor Tyrosine Kinase Inhibitor GW786034 in Patients with Metastatic Urothelial Cancer Dr HO Wing Ming
2009.386 A randomized phase III, double-blind, placebo-controlled multicenter trial of Everolimus in combination with Trastuzumab and Paclitaxel, as first line therapy in women with HER2 positive locally advanced or metastatic breast cancer Dr. HO Wing Ming
2016.032 Learning Ultrasound in Critical Care (LUCC) Dr. HO Wing Sze
何穎詩
2012.133 A Randomized, Open Label, Multi-National Study of Cabazitaxel At 25 mg/m_ Every 3 Weeks in Combination With Prednisone Compared To Mitoxantrone in Combination With Prednisone in Asian Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen Dr HO Wing-Ming
2021.573 Initial Asian experience of the branched E-vita Open NEO in complex aortic pathologies Dr. HO Yan Kit
2022.114 Retrospective record review on timing of post adult cardiac surgery and Coronavirus disease 2019 vaccination Dr. HO Yan Kit
何殷傑
2012.551 Predicting Vancomycin Trough Concentrations for Increased Trough Targets in Chinese Population: Comparison of Five Approaches Miss Ho Yan Yan Wendy
2015.543 Equipment Preference of Hong Kong Ambulance in Mountain Rescue Mr. HO Yiu Nam
何燿南
2008.002 Functional Significance of Apolipoprotein Gene Polymorphisms Prof. HO YUAN-YUAN
2008.270 An Exploratory Study of the Stresses and Needs of Chinese Parents During the Hospitalization of Their Preterm Infants Miss Ho Yuen Wah
2019.682 The Prevalence of Bone Density Monitoring and Predictive Factors for Aromatase Inhibitor-related Bone Fractures in Postmenopausal Women with Breast Cancer Mr. HO Yuk Nam
何煜南
2012.039 Effect of antipsychotics on risk of pneumonia and all-cause mortality in elderly patients with dementia: a 1-year retrospective study Ms Ho_x000D_So Wing Lam_x000D_In Yung
2018.401 A survey of stress, anxiety and quality of life in children with chronic and severe illnesses Prof. HON Ellis Kam Lun
韓錦倫
2018.249 Seeing the Invisible – Effectiveness Study on Holistic Intervention for Children with Eczema And their caregivers Prof. HON Ellis Kam Lun
韓錦倫
2018.248 Effect of a topical spray on itch relief in moderate-to-severe childhood eczema Prof. HON Ellis Kam Lun
韓錦倫
2001.489 A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of The Therapeutic Effect And Safety Of A Traditional Chinese Medicine (TCM) For Atopic Dermatitis In Children Prof. HON Ellis Kam Lun
2015.588 Treatment of Atopic Dermatitis Complicated with Staphylococcus aureus –Using Tea Bath: A Pilot Study Prof. HON Ellis Kam Lun
韓錦倫
2017.361 Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa Prof. HON Ellis Kam Lun
韓錦倫醫生
2015.676 A survey on quality of life and asthma control in Hong Kong, Macau and Shenzhen Prof. HON Ellis Kam Lun
韓錦倫
2015.075 Efficacy and tolerability of a multi-action emollient for childhood atopic eczema: a randomized controlled trial Prof. HON Ellis Kam Lun
韓錦倫
2016.118 Epidemiology of patients seen at the pediatric dermatology clinic Prof. HON Ellis Kam Lun
韓錦倫
2018.105 Survey on symptomatology of atopic eczema based on Western and Chinese Medicine disciplines in Children attending Paediatric dermatology clinic Prof. HON Ellis Kam Lun
韓錦倫
2016.018 Determining regulatory T and B cell dysregulation in childhood atopic eczema Prof. HON Ellis Kam Lun
韓錦倫
2016.267 Acceptability and efficacy of topical and systemic treatment in childhood-onset Atopic Dermatitis Prof. HON Ellis Kam Lun
韓錦倫
2018.086 Intestinal dysbiosis in eczema and airway allergies in twins Prof. HON Ellis Kam Lun
韓錦倫
2017.399 Effect of pine-tar shower on itch and disease severity in moderate-to-severe childhood eczema Prof. HON Ellis Kam Lun
韓錦倫
2016.116 Review of spectrum of paediatric diseases at a teaching hospital Prof. HON Ellis Kam Lun
韓錦倫
2017.159 Creating a Novel Topical Agent of Herbal Origin for Atopic Dermatitis through Evidence-Based Research Procedures Prof. HON Ellis Kam Lun
韓錦倫
2016.269 Microbiota Profile in Allergic Rhinoconjunctivitis Prof. HON Ellis Kam Lun
韓錦倫
2014.414 Respiratory pathogens in the PICU Prof. HON Ellis Kam Lun
2016.027 Topically applied allogeneic umbilical cord lining membrane-derived mesenchymal stem cells (MSCs) secretome for wound healing in moderate-to-severe childhood atopic eczema: A pilot study Prof. HON Ellis Kam Lun
韓錦倫
2023.037 A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease Prof. HON Ellis Kam Lun
韓錦倫
2021.377 Interdependent Quality of Life in Parent-Child Dyads Adjusting to Eczema: Effects of a Randomized Controlled Trial of the Integrative Body-Mind-Spirit Group Intervention Prof. HON Ellis Kam Lun
2020.029 Survey on eczema control and management Dr. HON Kam Lun
韓錦倫
2017.518 A review of efficacy of health care education/advice on corticosteroid phobia/fear in childhood atopic eczema Prof. HON Kam Lun
韓錦倫
2016.387 Comparison of the severity of respiratory syncytial virus infection between children with heart diseases and without: a multicentre review in Hong Kong Prof. HON Kam Lun E.
2010.171 Staphylococcus aureus sensitivity pattern and topical treatment with combination antibiotic/corticosteroid therapy in childhood eczema Prof Hon Kam Lun Ellis
2014.057 Community -based immunization survey in primary school students. Professor Hon Kam Lun Ellis
2010.100 Filaggrin null mutations and dermatologic parameters in predicting eczema severity for childhood atopic dermatitis Prof Hon Kam Lun Ellis
2011.362 The ideal moisturizer for eczema: a survey of parents' perspective Professor Hon Kam Lun Ellis
2010.126 Identification of severe acute viral and atypical bacterial infections by multiplex PCR assays in pediatric intensive care (PICU) patients Prof Hon Kam Lun Ellis
2014.093 Multi-center, randomized, double-blind clinical trial: Impact of home visits by nurse educator to improve compliance and efficacy of topical treatment for childhood eczema Professor Hon Kam Lun Ellis

Page 101 of 262.